Decision curve analysis using the infected pancreatic necrosis (IPN) prediction model comparing with other scores in derivation set. (IMAGE)
Caption
Black line (none): net benefit when we assume that no patients with acute pancreatitis (AP) will have the outcome (IPN) and do not intervene; grey line (all): net benefit when we assume that all patients with AP will have the IPN and intervene; red line (IPN model) = net benefit when we manage patients with AP according to the predicted risk of the IPN estimated by the IPN prediction model; orange line (BISAP score): net benefit when we manage patients with AP according to the predicted risk of the IPN estimated by BISAP score; blue line (APACHE II score): net benefit when we manage patients with AP according to the predicted risk of the IPN estimated by APACHE II score; cyan line (Marshall score): net benefit when we manage patients with according to the predicted risk of the IPN estimated by Marshall score; brown line (SOFA score): net benefit when we manage patients with AP according to the predicted risk of the IPN estimated by SOFA score. APACHE II, Acute Physiology and Chronic Health Evaluation II; BISAP, Beside Index for Severity in Acute Pancreatitis; SOFA, Sepsis-related Organ Failure Assessment.
Credit
By Kai Song, Wenhua He, Zuoyan Wu, Jie Meng, Wei Tian, Shicheng Zheng, Dong Mu, Ruifeng Wang, Hongda Chen, Yin Zhu, Dong Wu
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted.
License
CC BY-NC